Matches in Nanopublications for { ?s ?p "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP200919.RAeQ-BZtP57AXZhbHw6snGdoY7MvHugPd7uU60sUuAYcw130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP200919.RAeQ-BZtP57AXZhbHw6snGdoY7MvHugPd7uU60sUuAYcw130_provenance.
- NP264363.RAcDg2NpcpBV1PCWRSO-RdeVc7xtemx2zHuodzM01W0OA130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264363.RAcDg2NpcpBV1PCWRSO-RdeVc7xtemx2zHuodzM01W0OA130_provenance.
- NP669625.RAWCOFL7ZYI6atNjmh97aRJmydaCxDYVdLzg7XnVsdrAM130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP669625.RAWCOFL7ZYI6atNjmh97aRJmydaCxDYVdLzg7XnVsdrAM130_provenance.
- assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP373703.RA9twt05ufvi0znNHBXLKtuGqxr44-4VAW0IHfEWMgNsA130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373703.RA9twt05ufvi0znNHBXLKtuGqxr44-4VAW0IHfEWMgNsA130_provenance.
- NP217727.RAQBNQl7krCtnfL---tshZMyyUkbYGuHBYnCqczbwnxek130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP217727.RAQBNQl7krCtnfL---tshZMyyUkbYGuHBYnCqczbwnxek130_provenance.
- NP944514.RA0-fW52hi3fJYb8XDTh_gqiTMmADCnhao1iD55g_Emr4130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP944514.RA0-fW52hi3fJYb8XDTh_gqiTMmADCnhao1iD55g_Emr4130_provenance.
- NP951319.RAf6GWVr0TGFDUfcznLx3eApy-ajMqlDEnc4dxXPf5O1w130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP951319.RAf6GWVr0TGFDUfcznLx3eApy-ajMqlDEnc4dxXPf5O1w130_provenance.
- NP349364.RAr53e1GCZWbsUhIcls8WQCbNgamdDyB_VLWavnL5CeTc130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349364.RAr53e1GCZWbsUhIcls8WQCbNgamdDyB_VLWavnL5CeTc130_provenance.
- NP349367.RAkNyUfyaYSAFsY9u37EegqEQKrqTY77557VvyUgg5izo130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349367.RAkNyUfyaYSAFsY9u37EegqEQKrqTY77557VvyUgg5izo130_provenance.
- NP349366.RAJJ375-nRH3UZjwD-4GtFH7Jb117J_7VhPGw5j8L0q2E130_assertion description "[In conclusion, slow-acetylator status of NAT2 is a significant susceptibility risk factor for antituberculosis drug-induced hepatitis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP349366.RAJJ375-nRH3UZjwD-4GtFH7Jb117J_7VhPGw5j8L0q2E130_provenance.